- Home
- ATER
ATER
Aterian Inc.
as 04-25-2025 4:00pm EST
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SUMMIT |
| Market Cap: | 15.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 107.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.56 - $3.84 | Next Earning Date: | 05-06-2025 |
| Revenue: | $99,045,000 | Revenue Growth: | -30.53% |
| Revenue Growth (this year): | 5.62% | Revenue Growth (next year): | 8.63% |
Latest Aterian Inc. News
ATER Breaking Stock News: Dive into ATER Ticker-Specific Updates for Smart Investing
Insider Monkey
a month ago
Is Aterian Inc. (ATER) the Popular Penny Stock on Robinhood to Watch?
Thomson Reuters StreetEvents
a month ago
Q4 2024 Aterian Inc Earnings Call
GuruFocus.com
a month ago
Aterian Inc (ATER) Q4 2024 Earnings Call Highlights: Strategic Streamlining and Margin ...
Associated Press Finance
a month ago
Aterian: Q4 Earnings Snapshot
GlobeNewswire
a month ago
Aterian Reports Fourth Quarter & Full Year 2024 Results
GlobeNewswire
a month ago
Aterian Announces Share Repurchase Program
GlobeNewswire
2 months ago
Aterian Sets Date for Fourth Quarter & Full Year 2024 Earnings Announcement & Investor Conference Call
GlobeNewswire
2 months ago
Aterian Issues Letter to Shareholders
Compare ATER vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATER Aterian Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.